106 related articles for article (PubMed ID: 1596091)
1. Recent progress toward understanding the molecular biology of von Recklinghausen neurofibromatosis.
Gutmann DH; Collins FS
Ann Neurol; 1992 May; 31(5):555-61. PubMed ID: 1596091
[TBL] [Abstract][Full Text] [Related]
2. Analysis of the neurofibromatosis type 1 (NF1) GAP-related domain by site-directed mutagenesis.
Gutmann DH; Boguski M; Marchuk D; Wigler M; Collins FS; Ballester R
Oncogene; 1993 Mar; 8(3):761-9. PubMed ID: 8437860
[TBL] [Abstract][Full Text] [Related]
3. The hunt for the neurofibromatosis gene.
Goldberg NS; Collins FS
Arch Dermatol; 1991 Nov; 127(11):1705-7. PubMed ID: 1952978
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of neurofibromin, S-100 protein, and leu-7 and mutation analysis of the NF1 gene at codon 1423 in osteofibrous dysplasia.
Sakamoto A; Oda Y; Oshiro Y; Tamiya S; Iwamoto Y; Tsuneyoshi M
Hum Pathol; 2001 Nov; 32(11):1245-51. PubMed ID: 11727265
[TBL] [Abstract][Full Text] [Related]
5. [Characterization of the neurofibromatosis type 1 gene and neurofibromin's role in cells].
Sakai A
Nihon Rinsho; 2000 Jul; 58(7):1426-9. PubMed ID: 10921317
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid proteomic analysis reveals dysregulation of methionine aminopeptidase-2 expression in human and mouse neurofibromatosis 1-associated glioma.
Dasgupta B; Yi Y; Hegedus B; Weber JD; Gutmann DH
Cancer Res; 2005 Nov; 65(21):9843-50. PubMed ID: 16267007
[TBL] [Abstract][Full Text] [Related]
7. The genetic and molecular pathogenesis of NF1 and NF2.
Yohay KH
Semin Pediatr Neurol; 2006 Mar; 13(1):21-6. PubMed ID: 16818172
[TBL] [Abstract][Full Text] [Related]
8. Glioma formation in neurofibromatosis 1 reflects preferential activation of K-RAS in astrocytes.
Dasgupta B; Li W; Perry A; Gutmann DH
Cancer Res; 2005 Jan; 65(1):236-45. PubMed ID: 15665300
[TBL] [Abstract][Full Text] [Related]
9. [Von Recklinghausen neurofibromatosis gene (NF1) and its product].
Hovnanian A; Laplanche JL; Vidaud M
Ann Dermatol Venereol; 1992; 119(5):385-9. PubMed ID: 1530255
[No Abstract] [Full Text] [Related]
10. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
[TBL] [Abstract][Full Text] [Related]
11. Molecular targets for emerging anti-tumor therapies for neurofibromatosis type 1.
Dilworth JT; Kraniak JM; Wojtkowiak JW; Gibbs RA; Borch RF; Tainsky MA; Reiners JJ; Mattingly RR
Biochem Pharmacol; 2006 Nov; 72(11):1485-92. PubMed ID: 16797490
[TBL] [Abstract][Full Text] [Related]
12. The Ras inhibitor farnesylthiosalicylic acid as a potential therapy for neurofibromatosis type 1.
Barkan B; Starinsky S; Friedman E; Stein R; Kloog Y
Clin Cancer Res; 2006 Sep; 12(18):5533-42. PubMed ID: 17000690
[TBL] [Abstract][Full Text] [Related]
13. Hyperactive Ras as a therapeutic target in neurofibromatosis type 1.
Weiss B; Bollag G; Shannon K
Am J Med Genet; 1999 Mar; 89(1):14-22. PubMed ID: 10469432
[TBL] [Abstract][Full Text] [Related]
14. Mid-aortic syndrome with renovascular hypertension and multisystem involvement in a girl with familiar neurofibromatosis von Recklinghausen type 1.
Petrak B; Bendova S; Seeman T; Klein T; Lisy J; Zatrapa T; Marikova T
Neuro Endocrinol Lett; 2007 Dec; 28(6):734-8. PubMed ID: 18063929
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic analyses in neurofibromatosis type 1 patients with tumors.
Oguzkan S; Terzi YK; Cinbis M; Anlar B; Aysun S; Ayter S
Cancer Genet Cytogenet; 2006 Mar; 165(2):167-71. PubMed ID: 16527612
[TBL] [Abstract][Full Text] [Related]
16. Neurofibromin and NF1 gene analysis in composite pheochromocytoma and tumors associated with von Recklinghausen's disease.
Kimura N; Watanabe T; Fukase M; Wakita A; Noshiro T; Kimura I
Mod Pathol; 2002 Mar; 15(3):183-8. PubMed ID: 11904334
[TBL] [Abstract][Full Text] [Related]
17. Activation of the tyrosinase gene promoter by neurofibromin.
Suzuki H; Takahashi K; Yasumoto K; Shibahara S
Biochem Biophys Res Commun; 1994 Dec; 205(3):1984-91. PubMed ID: 7811291
[TBL] [Abstract][Full Text] [Related]
18. Two NF1 mutations: frameshift in the GAP-related domain, and loss of two codons toward the 3' end of the gene.
Abernathy CR; Colman SD; Kousseff BG; Wallace MR
Hum Mutat; 1994; 3(4):347-52. PubMed ID: 8081387
[TBL] [Abstract][Full Text] [Related]
19. Modulation of neurofibromatosis type 1 gene expression during in vitro myoblast differentiation.
Gutmann DH; Cole JL; Collins FS
J Neurosci Res; 1994 Feb; 37(3):398-405. PubMed ID: 8176761
[TBL] [Abstract][Full Text] [Related]
20. Loss of NF1 results in activation of the Ras signaling pathway and leads to aberrant growth in haematopoietic cells.
Bollag G; Clapp DW; Shih S; Adler F; Zhang YY; Thompson P; Lange BJ; Freedman MH; McCormick F; Jacks T; Shannon K
Nat Genet; 1996 Feb; 12(2):144-8. PubMed ID: 8563751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
